| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c1407305b111544dbf55c3eebbdf89e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b54f9bc6eb84cbd35f95cc4e5c457b0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9dc147e9bcbd348d209d544107f548e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b41fe5b13fe93b2199fd6d48d00e9b51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_076719c8139ea09a30ac5fb6c373c83a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_289a3b0bd945769757010aaaff6632f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5a859d06dcaefa3b4c8eb19ea47ef54 |
| publicationDate |
2021-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3887401-A2 |
| titleOfInvention |
Methods for treating dysregulated lipid metabolism |
| abstract |
Certain embodiments described herein provide a method for treating dysregulated lipid metabolism and/or inflammation in a mammal in need thereof, comprising administering to the mammal an effective amount of an agonist anti-triggering receptor expressed on myeloid cells 2 (TREM2) antibody. |
| priorityDate |
2018-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |